Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
FDA Approves Novo Nordisk’s Rybelsus For Cardiovascular Risk Reduction In Type 2 Diabetes Patients Finances October 18, 2025 (RTTNews) – Novo Nordisk introduced that the US Meals and Drug Administration has permitted Rybelsus—the one oral GLP-1 remedy—for decreasing…
